- Home
- LEG vs PVLA Comparison
LEG vs PVLA Comparison
Compare LEG & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEG | PVLA |
|---|---|---|
| Founded | 1883 | 2015 |
| Country | United States | United States |
| Employees | 15900 | 14 |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEG | PVLA |
|---|---|---|
| Price | $10.80 | $122.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | $10.50 | ★ $171.87 |
| AVG Volume (30 Days) | ★ 3.7M | 202.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ 145.31 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $5,203,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.73 | $104,350.18 |
| P/E Ratio | $6.54 | ★ N/A |
| Revenue Growth | ★ 1.37 | N/A |
| 52 Week Low | $7.86 | $20.20 |
| 52 Week High | $13.00 | $151.18 |
Technical Indicators
Market Signals| Indicator | LEG | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 47.40 |
| Support Level | $9.28 | $108.99 |
| Resistance Level | $11.94 | $135.23 |
| Average True Range (ATR) | 0.48 | 6.38 |
| MACD | -0.00 | -0.88 |
| Stochastic Oscillator | 40.25 | 10.14 |
Price Performance
Historical ComparisonAbout LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.